A 5-year-old girl from Kerala with β-thalassemia intermedia is being evaluated. Which of the following statements about thalassemia intermedia is NOT correct?

Explanation

## Thalassemia Intermedia: Clinical and Pathologic Features ### Definition and Severity Spectrum Thalassemia intermedia occupies the middle ground between thalassemia trait (asymptomatic) and thalassemia major (transfusion-dependent): - **Hemoglobin level:** 7–10 g/dL (moderate anemia) - **Transfusion requirement:** Minimal or none (unlike major) - **Clinical severity:** Variable; depends on genotype and degree of β-globin chain deficit ### Pathophysiology | Mechanism | Contribution to Anemia | |-----------|------------------------| | **Ineffective erythropoiesis** | Intramedullary hemolysis of abnormal RBC precursors | | **Hemolysis** | Circulating RBC destruction (shorter RBC lifespan) | | **Imbalanced globin chains** | Excess α chains precipitate, causing oxidative damage | **High-Yield:** Both ineffective erythropoiesis AND hemolysis contribute to anemia in thalassemia intermedia, making it more severe than trait but less severe than major. ### Splenomegaly in Thalassemia Intermedia **Key Point:** Splenomegaly in thalassemia intermedia is **MARKED and SIGNIFICANT**, NOT mild or absent. Reasons for prominent splenomegaly: 1. **Extramedullary hematopoiesis** — the spleen becomes a major site of RBC production 2. **Hemolysis** — splenic sequestration and destruction of abnormal RBCs 3. **Iron overload** — secondary hemochromatosis (though less than major) 4. **Chronic stimulation** — years of compensatory erythropoiesis Splenomegaly can become massive (20–30 cm) and may cause: - Splenic infarction - Hemolytic crises - Portal hypertension - Pancytopenia (hypersplenism) ### Comparison: Splenomegaly Across Thalassemia Types | Type | Splenomegaly Severity | Reason | |------|----------------------|--------| | **Thalassemia trait** | Absent or minimal | Mild anemia, minimal hemolysis | | **Thalassemia intermedia** | **Marked (20–30 cm)** | Significant extramedullary hematopoiesis + hemolysis | | **Thalassemia major** | Massive (can exceed 30 cm) | Severe extramedullary hematopoiesis + transfusions | ### Why Option 3 Is Incorrect **Warning:** A common misconception is that splenomegaly is mild in thalassemia intermedia. In reality: - Splenomegaly is **marked and often massive** - It is a defining clinical feature of thalassemia intermedia - Splenic complications (infarction, hypersplenism) are common ### Common Forms of Thalassemia Intermedia 1. **HbE-β-thalassemia** (Southeast Asia) — very common 2. **β-thalassemia with mild mutations** (e.g., β^+^ mutations) 3. **Hemoglobin Lepore** (rare) 4. **α-thalassemia with 3 gene deletions** (HbH disease) ### Clinical Pearl Thalassemia intermedia patients often present in adolescence or early adulthood with complications of chronic hemolysis (gallstones, leg ulcers, bone disease) and massive splenomegaly — not the transfusion-dependent crisis picture of thalassemia major. [cite:Robbins 10e Ch 12]